Literature DB >> 15720994

Risk factors for the intermediate outcome of morbid obesity after laparoscopically placed adjustable gastric banding.

Oliver Thomusch1, Tobias Keck, Ernst V Dobschütz, Christoph Wagner, Klaus Dieter Rückauer, Ulrich Theodor Hopt.   

Abstract

BACKGROUND: The overall long-term results of medical treatment for morbid obesity are poor. Surgery is the only treatment option to obtain long-term weight reduction. Analysis of risk factors for treatment success of laparoscopically placed gastric banding (LGB) has not been available until now.
METHODS: Prospective study with 99 patients with LGB between January 1997 and July 2003. The parameters assessed as risk factors included onset of obesity, feeling of postprandial satiety, and initial body mass index (BMI).
RESULTS: Median follow-up was 36 months (3 to 72). Independent prognostic factors of excess body weight reduction (>25%) were for the first postoperative year: onset of obesity as an adolescent (relative risk [RR] 0.21), an initial BMI <45 kg/m(2) (RR 4.76), and a BMI between 45.1 and 50 kg/m(2) (RR 3.23). After the second year, independent prognostic factors were as follows: feeling of postprandial satiety (RR 5.26) and an initial BMI <45 kg/m(2) (RR 3.03).
CONCLUSION: LGB is suitable to achieve intermediate weight reduction in patients with morbid obesity. To obtain the best results, patients should be treated before they achieve a BMI >45 kg/m(2). Additionally a postprandial feeling of satiety after LGB is mandatory for good long-term results.

Entities:  

Mesh:

Year:  2005        PMID: 15720994     DOI: 10.1016/j.amjsurg.2004.04.015

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  A 5-year experience of laparoscopic adjustable gastric banding in China.

Authors:  Qiaojun Han; Yue Chen; Jianbing Zhuge; Zhaolong Zhang; Dajin Zou
Journal:  Obes Surg       Date:  2013-02       Impact factor: 4.129

3.  SLEEVE GASTRECTOMY IN PATIENTS WITH MORBID OBESITY AND HIV.

Authors:  José Máximo Costa Pinto; Marianna Gomes Cavalcanti Leite de Lima; Ana Luiza Melo Cavalcanti de Almeida; Marcelo Gonçalves Sousa
Journal:  Arq Bras Cir Dig       Date:  2016
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.